272 related articles for article (PubMed ID: 12794159)
1. Aspirin-triggered lipoxin A4 and B4 analogs block extracellular signal-regulated kinase-dependent TNF-alpha secretion from human T cells.
Ariel A; Chiang N; Arita M; Petasis NA; Serhan CN
J Immunol; 2003 Jun; 170(12):6266-72. PubMed ID: 12794159
[TBL] [Abstract][Full Text] [Related]
2. Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 inhibit human neutrophil migration: comparisons between synthetic 15 epimers in chemotaxis and transmigration with microvessel endothelial cells and epithelial cells.
Fierro IM; Colgan SP; Bernasconi G; Petasis NA; Clish CB; Arita M; Serhan CN
J Immunol; 2003 Mar; 170(5):2688-94. PubMed ID: 12594298
[TBL] [Abstract][Full Text] [Related]
3. Selectivity of recombinant human leukotriene D(4), leukotriene B(4), and lipoxin A(4) receptors with aspirin-triggered 15-epi-LXA(4) and regulation of vascular and inflammatory responses.
Gronert K; Martinsson-Niskanen T; Ravasi S; Chiang N; Serhan CN
Am J Pathol; 2001 Jan; 158(1):3-9. PubMed ID: 11141472
[TBL] [Abstract][Full Text] [Related]
4. Lipoxin A(4) and aspirin-triggered 15-epi-lipoxin A(4) antagonize TNF-alpha-stimulated neutrophil-enterocyte interactions in vitro and attenuate TNF-alpha-induced chemokine release and colonocyte apoptosis in human intestinal mucosa ex vivo.
Goh J; Baird AW; O'Keane C; Watson RW; Cottell D; Bernasconi G; Petasis NA; Godson C; Brady HR; MacMathuna P
J Immunol; 2001 Sep; 167(5):2772-80. PubMed ID: 11509622
[TBL] [Abstract][Full Text] [Related]
5. Aspirin-triggered 15-epi-lipoxin A4 (LXA4) and LXA4 stable analogues are potent inhibitors of acute inflammation: evidence for anti-inflammatory receptors.
Takano T; Fiore S; Maddox JF; Brady HR; Petasis NA; Serhan CN
J Exp Med; 1997 May; 185(9):1693-704. PubMed ID: 9151906
[TBL] [Abstract][Full Text] [Related]
6. Aspirin-triggered lipoxin A4 and lipoxin A4 up-regulate transcriptional corepressor NAB1 in human neutrophils.
Qiu FH; Devchand PR; Wada K; Serhan CN
FASEB J; 2001 Dec; 15(14):2736-8. PubMed ID: 11687510
[TBL] [Abstract][Full Text] [Related]
7. An aspirin-triggered lipoxin A4 stable analog displays a unique topical anti-inflammatory profile.
Schottelius AJ; Giesen C; Asadullah K; Fierro IM; Colgan SP; Bauman J; Guilford W; Perez HD; Parkinson JF
J Immunol; 2002 Dec; 169(12):7063-70. PubMed ID: 12471142
[TBL] [Abstract][Full Text] [Related]
8. Neutrophil-mediated changes in vascular permeability are inhibited by topical application of aspirin-triggered 15-epi-lipoxin A4 and novel lipoxin B4 stable analogues.
Takano T; Clish CB; Gronert K; Petasis N; Serhan CN
J Clin Invest; 1998 Feb; 101(4):819-26. PubMed ID: 9466977
[TBL] [Abstract][Full Text] [Related]
9. Lipoxins, aspirin-triggered epi-lipoxins, lipoxin stable analogues, and the resolution of inflammation: stimulation of macrophage phagocytosis of apoptotic neutrophils in vivo.
Mitchell S; Thomas G; Harvey K; Cottell D; Reville K; Berlasconi G; Petasis NA; Erwig L; Rees AJ; Savill J; Brady HR; Godson C
J Am Soc Nephrol; 2002 Oct; 13(10):2497-507. PubMed ID: 12239238
[TBL] [Abstract][Full Text] [Related]
10. Lipoxin (LX)A4 and aspirin-triggered 15-epi-LXA4 inhibit tumor necrosis factor 1alpha-initiated neutrophil responses and trafficking: regulators of a cytokine-chemokine axis.
Hachicha M; Pouliot M; Petasis NA; Serhan CN
J Exp Med; 1999 Jun; 189(12):1923-30. PubMed ID: 10377187
[TBL] [Abstract][Full Text] [Related]
11. Lipoxins, aspirin-triggered 15-epi-lipoxin stable analogs and their receptors in anti-inflammation: a window for therapeutic opportunity.
Serhan CN; Levy BD; Clish CB; Gronert K; Chiang N
Ernst Schering Res Found Workshop; 2000; (31):143-85. PubMed ID: 10943332
[TBL] [Abstract][Full Text] [Related]
12. Identification of a human enterocyte lipoxin A4 receptor that is regulated by interleukin (IL)-13 and interferon gamma and inhibits tumor necrosis factor alpha-induced IL-8 release.
Gronert K; Gewirtz A; Madara JL; Serhan CN
J Exp Med; 1998 Apr; 187(8):1285-94. PubMed ID: 9547339
[TBL] [Abstract][Full Text] [Related]
13. Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 inhibit peroxynitrite formation, NF-kappa B and AP-1 activation, and IL-8 gene expression in human leukocytes.
József L; Zouki C; Petasis NA; Serhan CN; Filep JG
Proc Natl Acad Sci U S A; 2002 Oct; 99(20):13266-71. PubMed ID: 12235371
[TBL] [Abstract][Full Text] [Related]
14. Lipoxin A4 antagonizes the mitogenic effects of leukotriene D4 in human renal mesangial cells. Differential activation of MAP kinases through distinct receptors.
McMahon B; Stenson C; McPhillips F; Fanning A; Brady HR; Godson C
J Biol Chem; 2000 Sep; 275(36):27566-75. PubMed ID: 10869343
[TBL] [Abstract][Full Text] [Related]
15. Activation of lipoxin A(4) receptors by aspirin-triggered lipoxins and select peptides evokes ligand-specific responses in inflammation.
Chiang N; Fierro IM; Gronert K; Serhan CN
J Exp Med; 2000 Apr; 191(7):1197-208. PubMed ID: 10748237
[TBL] [Abstract][Full Text] [Related]
16. Inosine monophosphate and aspirin-triggered 15-epi-lipoxin A4 act in concert to regulate neutrophil trafficking: additive actions of two new endogenous anti-inflammatory mediators.
Wada K; Qiu FH; Stahl GL; Serhan CN
J Hematother Stem Cell Res; 2001 Feb; 10(1):75-9. PubMed ID: 11276361
[TBL] [Abstract][Full Text] [Related]
17. Influence of lipoxin A(4) and other lipoxygenase-derived eicosanoids on tissue factor expression.
Maderna P; Godson C; Hannify G; Murphy M; Brady HR
Am J Physiol Cell Physiol; 2000 Oct; 279(4):C945-53. PubMed ID: 11003574
[TBL] [Abstract][Full Text] [Related]
18. Lipoxin A4 and aspirin-triggered 15-epi-LXA4 inhibit tumor necrosis factor-alpha-initiated neutrophil responses and trafficking: novel regulators of a cytokine-chemokine axis relevant to periodontal diseases.
Pouliot M; Serhan CN
J Periodontal Res; 1999 Oct; 34(7):370-3. PubMed ID: 10685363
[TBL] [Abstract][Full Text] [Related]
19. Anti-inflammatory actions of lipoxin A(4) stable analogs are demonstrable in human whole blood: modulation of leukocyte adhesion molecules and inhibition of neutrophil-endothelial interactions.
Filep JG; Zouki C; Petasis NA; Hachicha M; Serhan CN
Blood; 1999 Dec; 94(12):4132-42. PubMed ID: 10590058
[TBL] [Abstract][Full Text] [Related]
20. Lipoxins and novel aspirin-triggered 15-epi-lipoxins (ATL): a jungle of cell-cell interactions or a therapeutic opportunity?
Serhan CN
Prostaglandins; 1997 Feb; 53(2):107-37. PubMed ID: 9112289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
